Xerri, Luc
Centre National de la Recherche Scientifique · Inserm · Aix-Marseille Université · Centre Hospitalier Universitaire de Lille · Centre Hospitalier Régional et Universitaire de Nancy · Centre de Recherche en Cancérologie de Marseille · Institut Paoli-Calmettes · Groupe de Recherche sur les formes Injectables et les Technologies Associées
3 papers on CoChatORCID 0000-0002-8672-9921
Most cited papers
- Verified
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer
Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., Houvenaeghel, G., Extra, J.-M., Bertucci, F., Jacquemier, J., et al. (2010) · Clinical Cancer Research
Cancer Cells and MetastasisBreast Cancer Treatment Studies
Cited by 732
- Verified
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Morschhauser, F., Fowler, N. H., Feugier, P., Bouabdallah, R., Tilly, H., Palomba, M. L., Fruchart, C., Libby, E. N., Casasnovas, R.-O., Flinn, I. W., et al. (2018) · New England Journal of Medicine
Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia Research
Cited by 373
- Verified
PD-1 is a novel regulator of human B-cell activation
Thibult, M.-L., Mamessier, E., Gertner-Dardenne, J., Pastor, S., Just-Landi, S., Xerri, L., Chetaille, B., & Olive, D. (2013) · International Immunology
T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers
Cited by 365
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free